VA-HILTON
24.1.2022 14:02:12 CET | Business Wire | Press release
Well-positioned to emerge from the pandemic stronger than ever, Hilton delivered a record year of development achievements. Already one of the world’s largest hotel companies, Hilton opened 414 properties, adding more than 67,100 rooms to its system, further emphasizing the scale, presence and leading brands of the company’s global portfolio.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220121005394/en/
“After a year of recovery and growth, it has been incredible to witness the resiliency of the travel industry and our team’s ability to embrace change while serving more guests in more hotels around the world,” said Chris Nassetta, President and CEO, Hilton. “We believe the desire to travel, experience new cultures and connect with others is core to the human experience. I can speak for all of us at Hilton when I say we’re looking forward to welcoming our guests and helping them make new memories in 2022.”
Global development efforts have continued to show strong performance through the pandemic. Hilton ended 2021 with more than 6,800 hotels across 18 brands in six continents, with robust net unit growth of 5.6%. The company’s development pipeline includes nearly 2,670 hotels representing approximately 408,000 rooms, nearly half of which are under construction.
“Hilton’s development continues to be a key performance indicator of how well-positioned we are for the long-term,” said Kevin Jacobs, CFO and president, global development, Hilton. “Hotel owners choose to work with us because of our premium commercial performance. With our capital light business model, we strive to maximize net unit growth, while continuing to deliver value for all our stakeholders.”
Celebrating A Year of Market and Category Milestones
- Historic Las Vegas Development: Hilton notably expanded its presence in the Las Vegas market, which is now home to 13 brands, including all three of our luxury brands, 36 hotels and more than 12,000 rooms. In June 2021, Hilton and Genting Group partnered in the historic opening of Resorts World Las Vegas , the largest multi-brand resort in Hilton’s history, integrating three premium brands – the largest Conrad Hotels & Resorts property in the world, one of the first LXR Hotels & Resorts locations in the U.S. and a marquee Hilton Hotels & Resorts hotel. Additionally, Curio Collection by Hilton re-emerged in Las Vegas with the introduction of Virgin Hotels Las Vegas, Curio Collection by Hilton .
- Significant All-Inclusive Expansion: Hilton’s all-inclusive portfolio expanded in 2021 with openings in the Caribbean and Latin America, including Hilton Cancun, an All-Inclusive Resort, Hilton Vallarta Riviera All-Inclusive Resort , Mangrove Beach Corendon Curaçao All-Inclusive Resort, Curio Collection by Hilton and The Yucatan Playa del Carmen All-Inclusive Resort, Tapestry Collection by Hilton .
- Hilton’s lifestyle brands gained momentum in Europe, the Middle East & Africa (EMEA) and Brazil. Canopy by Hilton made its debuts in France, UK and Spain. Motto by Hilton announced plans to open its first hotel in Europe with Motto Rotterdam Blaak in the Netherlands in 2022. Additionally, Brazil welcomed two Hilton brands with the debuts of Canopy by Hilton Sao Paulo Jardins and Almenat Hotel, Tapestry Collection by Hilton .
- Asia Pacific Growth: Hilton Nagasaki ’s flagship opening marked the company’s 500th hotel in Asia Pacific, while Hilton Lanzhou City Center ’s opening marked the 400th hotel in the Greater China and Mongolia region.
- Washington, D.C. Expansion: The company introduced its 25th hotel within the portfolio in Washington, D.C. with the debut of Hilton Washington DC Capitol Hill .
Recognizing Year of “Firsts” for the Brand Portfolios with Market Expansions
- Waldorf Astoria Hotels & Resorts expanded the brand’s West Coast presence with the opening of Waldorf Astoria Monarch Beach Resort & Club in Dana Pointe, California and signed a milestone management agreement with Orix Real Estate Corporation to expand the brand into Osaka, Japan in 2025.
- Management agreement was signed for the first Conrad Hotels & Resorts property in California with Conrad Los Angeles (opening Spring 2022) as well as the first in Tulum with Conrad Tulum Riviera Maya .
- LXR Hotels & Resorts was introduced in Africa and the Indian Ocean with Mango House Seychelles and in Asia Pacific with ROKU KYOTO, LXR Hotels & Resorts .
- Signia by Hilton debuted with the conversion and rebrand of Signia by Hilton Orlando Bonnet Creek . Additionally, Signia by Hilton Atlanta broke ground at Georgia World Congress Center.
- Curio Collection by Hilton surpassed 100 properties worldwide with the opening of Sable at Navy Pier Chicago, Curio Collection by Hilton .
- DoubleTree by Hilton extended its international reach to its 50th trading market with the opening of DoubleTree by Hilton Frankfurt Niederrad, the brand’s first in Germany.
- Tapestry Collection by Hilton introduced properties in Europe and the Chinese Mainland, including Atocha Hotel Madrid, Tapestry Collection by Hilton and Hollick Hotel Wen’an, Tapestry Collection by Hilton .
- Motto by Hilton announced plans to open its first hotels in Europe and Latin America in 2022 with Motto Rotterdam Blaak in the Netherlands and Motto Tulum in Mexico.
- Hilton Garden Inn entered into Australasia, South Korea, Thailand and Indonesia’s capital city Jakarta with Hilton Garden Inn Albany , Hilton Garden Inn Seoul Gangnam , Hilton Garden Inn Phuket Bang Tao and Hilton Garden Inn Jakarta Taman Palem , respectively. Additionally, the brand launched its large-scale franchise model in China , welcoming investors and independent owners to explore franchising opportunities.
- Hampton by Hilton celebrated milestones throughout the year, surpassing 2,700 open hotels and expanding into Ireland, Uzbekistan and Qatar, as well as the Cayman Islands with Hampton by Hilton Grand Cayman . Hampton also remains the fastest-growing international hotel brand in China, marking 200 open hotels, with an additional 600 signed development deals within the country. Additionally, starting 2022 strong, the brand was recognized for the 13th year in a row as the No. 1 hotel franchise by Entrepreneur ’s Franchise 500® , tying the record for most total No. 1 rankings in the Hotels & Motels category.
- Tru by Hilton opened its 200th hotel, adding nearly 100 hotels during the pandemic, and announced expansion into the Caribbean and Latin America, with developments in Brazil, Costa Rica, Dominican Republic, Mexico and Puerto Rico.
- Homewood Suites by Hilton unveiled a comprehensive brand refresh with a game-changing, all-new prototype – ‘Prototype 10.0’ – designed to offer added value and versatility for owners and developers, while exceeding the needs of guests who want the comforts of home.
- Home2 Suites by Hilton became one of the fastest-growing hotel brands as it reached 500 open properties in just 10 years and touts the largest pipeline in the U.S., with 437 properties in development. The brand also debuted in China , with the opening of the first of 1,000 Home2 Suites by Hilton properties in the region.
In addition to development milestones, Hilton continued to innovate to meet the evolving needs of travelers with the introduction of industry-leading programs and products, such as Confirmed Connecting Rooms by Hilton and Hilton Honors Digital Key Share , and the evolution of brand standards, including expanding its pet-friendly offerings . To learn more, visit newsroom.hilton.com .
About Hilton
Hilton (NYSE: HLT) is a leading global hospitality company with a portfolio of 18 world-class brands comprising more than 6,800 properties and more than 1 million rooms, in 122 countries and territories. Dedicated to fulfilling its founding vision to fill the earth with the light and warmth of hospitality, Hilton has welcomed more than 3 billion guests in its more than 100-year history, earned a top spot on the 2021 World’s Best Workplaces list and been recognized as a global leader on the Dow Jones Sustainability Indices for five consecutive years. In 2021, in addition to opening more than one hotel a day, Hilton introduced several industry-leading technology enhancements to improve the guest experience, including Digital Key Share, automated complimentary room upgrades and the ability to book confirmed connecting rooms. Through the award-winning guest loyalty program Hilton Honors, the nearly 128 million members who book directly with Hilton can earn Points for hotel stays and experiences money can’t buy. With the free Hilton Honors app , guests can book their stay, select their room, check in, unlock their door with a Digital Key and check out, all from their smartphone. Visit newsroom.hilton.com for more information, and connect with Hilton on Facebook , Twitter , LinkedIn , Instagram and YouTube .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220121005394/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
